51 related articles for article (PubMed ID: 20546881)
21. MMP-12-mediated by SARM-TRIF signaling pathway contributes to IFN-γ-independent airway inflammation and AHR post RSV infection in nude mice.
Long X; Li S; Xie J; Li W; Zang N; Ren L; Deng Y; Xie X; Wang L; Fu Z; Liu E
Respir Res; 2015 Feb; 16(1):11. PubMed ID: 25652021
[TBL] [Abstract][Full Text] [Related]
22. Comparison of temporal transcriptomic profiles from immature lungs of two rat strains reveals a viral response signature associated with chronic lung dysfunction.
Hines EA; Szakaly RJ; Leng N; Webster AT; Verheyden JM; Lashua AJ; Kendziorski C; Rosenthal LA; Gern JE; Sorkness RL; Sun X; Lemanske RF
PLoS One; 2014; 9(12):e112997. PubMed ID: 25437859
[TBL] [Abstract][Full Text] [Related]
23. Bispecific antibody derivatives with restricted binding functionalities that are activated by proteolytic processing.
Metz S; Panke C; Haas AK; Schanzer J; Lau W; Croasdale R; Hoffmann E; Schneider B; Auer J; Gassner C; Bossenmaier B; Umana P; Sustmann C; Brinkmann U
Protein Eng Des Sel; 2012 Oct; 25(10):571-80. PubMed ID: 22976197
[TBL] [Abstract][Full Text] [Related]
24. Long-term use of doxycycline can improve chronic asthma and possibly remodeling: the result of a pilot observation.
Bhattacharyya P; Paul R; Bhattacharjee P; Ghosh A; Dey R; Ghosh M; Sharma M
J Asthma Allergy; 2012; 5():33-7. PubMed ID: 22923997
[TBL] [Abstract][Full Text] [Related]
25. MiR-375 is downregulated in epithelial cells after IL-13 stimulation and regulates an IL-13-induced epithelial transcriptome.
Lu TX; Lim EJ; Wen T; Plassard AJ; Hogan SP; Martin LJ; Aronow BJ; Rothenberg ME
Mucosal Immunol; 2012 Jul; 5(4):388-96. PubMed ID: 22453679
[TBL] [Abstract][Full Text] [Related]
26. Cross-roads in the lung: immune cells and tissue interactions as determinants of allergic asthma.
Ramakrishna L; de Vries VC; Curotto de Lafaille MA
Immunol Res; 2012 Sep; 53(1-3):213-28. PubMed ID: 22447350
[TBL] [Abstract][Full Text] [Related]
27. Asthma in children and adolescents: a comprehensive approach to diagnosis and management.
Chang C
Clin Rev Allergy Immunol; 2012 Aug; 43(1-2):98-137. PubMed ID: 22187333
[TBL] [Abstract][Full Text] [Related]
28. Advances in pediatric asthma in 2010: addressing the major issues.
Szefler SJ
J Allergy Clin Immunol; 2011 Jan; 127(1):102-15. PubMed ID: 21211645
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinases in asthma and COPD.
Demedts IK; Brusselle GG; Bracke KR; Vermaelen KY; Pauwels RA
Curr Opin Pharmacol; 2005 Jun; 5(3):257-63. PubMed ID: 15907912
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinase-12 is a therapeutic target for asthma in children and young adults.
Mukhopadhyay S; Sypek J; Tavendale R; Gartner U; Winter J; Li W; Page K; Fleming M; Brady J; O'Toole M; Macgregor DF; Goldman S; Tam S; Abraham W; Williams C; Miller DK; Palmer CN
J Allergy Clin Immunol; 2010 Jul; 126(1):70-6.e16. PubMed ID: 20546881
[TBL] [Abstract][Full Text] [Related]
31. Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.
Li W; Li J; Wu Y; Rancati F; Vallese S; Raveglia L; Wu J; Hotchandani R; Fuller N; Cunningham K; Morgan P; Fish S; Krykbaev R; Xu X; Tam S; Goldman SJ; Abraham W; Williams C; Sypek J; Mansour TS
J Med Chem; 2009 Sep; 52(17):5408-19. PubMed ID: 19725580
[TBL] [Abstract][Full Text] [Related]
32. Association study of matrix metalloproteinase-12 gene polymorphisms and asthma in a Japanese population.
Yamaide F; Undarmaa S; Mashimo Y; Shimojo N; Arima T; Morita Y; Hirota T; Fujita K; Miyatake A; Doi S; Sato K; Suzuki S; Nishimuta T; Watanabe H; Hoshioka A; Tomiita M; Yamaide A; Watanabe M; Okamoto Y; Kohno Y; Tamari M; Hata A; Suzuki Y
Int Arch Allergy Immunol; 2013; 160(3):287-96. PubMed ID: 23075521
[TBL] [Abstract][Full Text] [Related]
33. [Polymorphism in promoter regions of matrix metalloproteinases (MMP1, MMP9, and MMP12) in chronic obstructive pulmonary disease patients].
Korytina GF; Akhmadishina LZ; Ianbaeva DG; Viktorova TV
Genetika; 2008 Feb; 44(2):242-9. PubMed ID: 18619044
[TBL] [Abstract][Full Text] [Related]
34. Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors.
Cataldo DD; Gueders MM; Rocks N; Sounni NE; Evrard B; Bartsch P; Louis R; Noel A; Foidart JM
Cell Mol Biol (Noisy-le-grand); 2003 Sep; 49(6):875-84. PubMed ID: 14656045
[TBL] [Abstract][Full Text] [Related]
35. Children with stable asthma have reduced airway matrix metalloproteinase-9 and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio.
Doherty GM; Kamath SV; de Courcey F; Christie SN; Chisakuta A; Lyons JD; Heaney LG; Ennis M; Shields MD
Clin Exp Allergy; 2005 Sep; 35(9):1168-74. PubMed ID: 16164443
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
